Concepedia

Dayana Herrera-Rios

DH

Statistics

Publications

4

Citations

131

H-Index

4

Active since

2017

Affiliations

German Cancer Research Center(Current)

West German Heart and Vascular Center Essen

University of Duisburg-Essen

Heinrich Heine University Düsseldorf

Capital Medical University

Dayana Herrera-Rios is an author at German Cancer Research Center specializing in oncology, medicine, and notch signaling activation.

Publications per year

2017–2023

4

Publications

4

CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells

Donata Maciaczyk, Daniel Picard, Lili Zhao et al. · British Journal of Cancer · 2017 · 41 citations · Full text

, , +17

Macrophages/Microglia Represent the Major Source of Indolamine 2,3-Dioxygenase Expression in Melanoma Metastases of the Brain

Dayana Herrera-Rios, Sadaf S. Mughal, Sarah Teuber‐Hanselmann et al. · Frontiers in Immunology · 2020 · 39 citations · Full text

, , +17

Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanoma

Luiza Martins Nascentes Melo, Dayana Herrera-Rios, Daniel Hinze et al. · Journal for ImmunoTherapy of Cancer · 2023 · 31 citations · Full text

, , +17

A computational guided, functional validation of a novel therapeutic antibody proposes Notch signaling as a clinical relevant and druggable target in glioma

Dayana Herrera-Rios, Guanzhang Li, Dilaware Khan et al. · Scientific Reports · 2020 · 20 citations · Full text

, , +17

1–4 of 4